Skip to main content
Log in

Non-specific elevation of immunoreactive trypsinogen in sick infants

  • Neonatology
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

To determine the effect of neonatal illness on immunoreactive trypsinogen (IRT) levels, the IRT values obtained in sick infants transferred to a neonatal intensive care ward were compared with those found in matched controls. IRT levels from dried blood spots collected on day 4–5 of life from 372 sick infants had a mean value of 0.095 log transformed multiples of the median, whilst controls had a mean of −0.013: a highly significant difference. Classification of the sick infants into principal diagnostic categories failed to show any group contributing disproportionately to the observation. In particular, the level of elevation observed in 33 infants with gut abnormalities such as bowel obstruction, duodenal atresia, exomphalos and gastroschisis, in which some degree of pancreatic obstruction might be expected, was not greater than in other hospitalised infants. These data show that sick infants are at increased risk of being identified by an IRT screening programme aimed at detecting infants with cystic fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CF:

cystic fibrosis

IRT:

immunoreactive trypsinogen

References

  1. Bowling FG, Brown ARD (1988) Newborn screening for cystic fibrosis using an enzyme-linked immunosorbent assay (ELISA) technique. Clin Chim Acta 171:157–262

    Google Scholar 

  2. Bowling FG, McGill JJ, Danks DM (1990) Newborn screening for cystic fibrosis: use of F508 mutation. Lancet I:925–926

    Google Scholar 

  3. Crossley JR, Elliott RB, Smith PA (1979) Dried-blood spot screening for cystic fibrosis in the newborn. Lancet I:472–474

    Google Scholar 

  4. King A, Mueller RF, Heeley AF, Roberton NRC (1986) Diagnosis of cystic fibrosis in premature infants. Pediatr Res 20: 536–541

    Google Scholar 

  5. Rock MJ, Mischler EH, Farrell PM, Bruns WT, Hassemer DJ, Leassig RH (1989) Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test. Pediatr Pulmonol 6:42–48

    Google Scholar 

  6. Ryley HC, Deam SM, Williams J, Alfaham M, Weller PH, Goodchild MC, Darter RA, Bradley D, Doge JA (1988) Neonatal screening for cystic fibrosis in Wales and the West Midlands. 1. Evaluation of immunoreactive trypsin test. J Clin Pathol 41:726–729

    Google Scholar 

  7. Wilcken B (1987) An evaluation of screening for cystic fibrosis. Genetics and epithelial cell dysfunction in cystic fibrosis. Liss, New York, pp 201–215

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ravine, D., Francis, R.I. & Danks, D.M. Non-specific elevation of immunoreactive trypsinogen in sick infants. Eur J Pediatr 152, 348–349 (1993). https://doi.org/10.1007/BF01956751

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01956751

Key words

Navigation